comparemela.com

Latest Breaking News On - Awakn - Page 3 : comparemela.com

Awakn Life Sciences Corp : Awakn Life Sciences Initiates Investigative Study of Novel Formulation of (S)-ketamine to Assess Dissociative Effect

Study Has Potential to Lead to In-Licensing Agreement and Accelerated Pathway to Phase II Toronto, Ontario (Newsfile Corp. - January 24, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE:

Gordo whittakerCelia morganAnthony tennysonLinkedin facebookAwakn life sciencesNewsfile corpAwakn life sciences corpStudy has potentialIn licensing agreementAccelerated pathwayLife sciencesAlcohol use disorderAwakn life

Awakn Life Sciences Corp : Awakn Life Sciences Reports Strong Q3 2022 Results with 27% Revenue Growth

And continued successful execution of R&D and Commercialization strategies Toronto, Ontario (Newsfile Corp. - December 15, 2022) - Awakn Life Sciences Corp.(NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn")

United kingdomNew yorkUnited statesCity ofGordo whittakerCatalent zydisAnthony tennysonLinkedin facebookAwakn life sciencesDrug development company to deepen ip moatInternational financial reporting standardsAwakn life sciences signs drug development agreementAwakn life sciences corpAwakn life sciences signs agreementNewsfile corpAwakn life sciences announces signing of lease

Awakn Life Sciences Corp : Awakn Life Sciences Phase III Trial to Be Delivered in the UK National Health Service (NHS)

Phase III trial confirmed to cost CA$3.75 million, with a UK Government agency funding 66% of this cost Toronto, Ontario (Newsfile Corp. - December 13, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB:

United kingdomUnited statesGordo whittakerCelia morganAnthony tennysonAnthony tennyson awaknLinkedin facebookAwakn life sciencesAwakn life sciences corpNational institute for healthNewsfile corpUniversity of exeter uoCare researchUnited kingdom department of healthUnited kingdom governmentLife sciences

Awakn Life Sciences Corp : Awakn Life Sciences Signs Its Third Licensing Partnership Agreement in North America, and First in New York

Awakn will Partner with Nushama, One of New York's Leading Ketamine-assisted Therapy Centers Toronto, Ontario (Newsfile Corp. - November 9, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF)

New yorkUnited statesRichard meloffGordo whittakerAnne donohoeAnthony tennysonLinkedin facebookAwakn life sciencesNushama coAwakn life sciences corpYork leading therapy centersLicensing partnershipNewsfile corpStrategic communicationsLeading ketamine assisted therapyLife sciences

Awakn Life Sciences Secures Financing to Expand Nordic Commercial Operations

TORONTO - Awakn Life Sciences Corp. , a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use. | October 26, 2022

United statesAnthony tennysonAwakn life sciences corpLife sciencesAlcohol use disorderAwakn osloLowan stewartRegional directorLoan agreementUnited states securities actNews publishingAwakn life sciences corp stock exchangePress releaseLcohol awkn ca05455w1086

vimarsana © 2020. All Rights Reserved.